The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts

被引:19
|
作者
Jamshidi, Mahin [2 ]
Shekari, Mohammad [1 ,2 ]
Nejatizadeh, Abdol Azim [1 ,2 ]
Malekzadeh, Keyanoush [1 ]
Baghershiroodi, Mahnaz [1 ]
Davudian, Parivash [2 ]
Dehghan, Farzaneh [1 ]
Jamshidi, Froogh [3 ]
机构
[1] Hormozgan Univ Med Sci, Res Ctr Mol Med, Bandar Abbas, Iran
[2] Hormozgan Univ Med Sci, Infect Res Ctr, Bandar Abbas, Iran
[3] Dermatol Private Clin, Bandar Abbas, Iran
关键词
Human papillomavirus; Genital warts; PCR; Typing; POLYMERASE-CHAIN-REACTION; CERVICAL-CANCER; ANOGENITAL WARTS; NESTED PCR; DNA CHIP; INFECTION; LESIONS; GENOTYPES; SAMPLES; GENE;
D O I
10.1007/s00404-012-2416-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human papillomaviruses (HPV) are etiologically associated with the development of virtually all genital warts. HPV-6 and HPV-11 are the most commonly detected HPV genotypes, but at least 20 other HPV genotypes have occasionally been found in genital wart tissue specimens. The aim of this study was to determine from 100 genital wart tissue specimens collected from female patients using multiplex gap-PCR technique the prevalence of various genital HPV among women with HPV genital warts in south of Iran. 100 genital wart tissue specimens were tested for the presence of HPV PG5/PG6 and also for HPV type using polymerase chain reaction (PCR). Based on the collected data, 73 (73 %) samples were detected positive for HPV DNA and 23 (23 %) samples out of 100 samples were detected negative for HPV DNA. 49 (49 %) and 67 (67 %) of patients were detected positive for HPV type 6 and 11, respectively. There was a significant association between marital status and HPV genotype 6 (OR = 0.51, 95 % CI = 0.37-0.70, P = 0.01). Nevertheless, no significant association was found between marriage and HPV genotype 11 (OR = 0.85, 95 % CI = 0.58-1, 24, P = 0.7). Similarly, this result was demonstrated, in combined marriage and HPV-general (OR = 0.80, 95 % CI = 0.62-0.05, P = 0.4). Concerning the prevalence of HPV in our study, determination of genital HPV prevalence and multiple infections among the normal population of women of Hormozgan Province is recommended.
引用
收藏
页码:1261 / 1267
页数:7
相关论文
共 50 条
  • [1] The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts
    Mahin Jamshidi
    Mohammad Shekari
    Abdol Azim Nejatizadeh
    Keyanoush Malekzadeh
    Mahnaz Baghershiroodi
    Parivash Davudian
    Farzaneh Dehghan
    Froogh Jamshidi
    Archives of Gynecology and Obstetrics, 2012, 286 : 1261 - 1267
  • [2] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 VaccineFor the Prevention of Genital Warts in Males
    Karly P. Garnock-Jones
    Anna R. Giuliano
    Drugs, 2011, 71 : 591 - 602
  • [3] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS, 2011, 71 (05) : 591 - 602
  • [4] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS IN R&D, 2012, 12 (04) : 235 - 238
  • [5] Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: Profile report
    Garnock-Jones K.P.
    Giuliano A.R.
    Drugs in R&D, 2012, 12 (4) : 235 - 238
  • [6] Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts
    Boxman, ILA
    Hogewoning, A
    Mulder, LHC
    Bavinck, JNB
    ter Schegget, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) : 2270 - 2273
  • [7] The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Silverberg, MJ
    Ahdieh, L
    Muñoz, A
    Anastos, K
    Burk, RD
    Cu-Uvin, S
    Duerr, A
    Greenblatt, RM
    Klein, RS
    Massad, S
    Minkoff, H
    Muderspach, L
    Palefsky, J
    Piessens, E
    Schuman, P
    Watts, H
    Shah, KV
    SEXUALLY TRANSMITTED DISEASES, 2002, 29 (08) : 427 - 435
  • [8] Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women
    Paul L. McCormack
    Elmar A. Joura
    BioDrugs, 2011, 25 : 339 - 343
  • [9] Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women
    McCormack, Paul L.
    Joura, Elmar A.
    BIODRUGS, 2011, 25 (05) : 339 - 343
  • [10] Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
    Munoz, Nubia
    Kjaer, Susanne K.
    Sigurdsson, Kristjan
    Iversen, Ole-Erik
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Brown, Darron R.
    Koutsky, Laura A.
    Tay, Eng Hseon
    Garcia, Patricia J.
    Ault, Kevin A.
    Garland, Suzanne M.
    Leodolter, Sepp
    Olsson, Sven-Eric
    Tang, Grace W. K.
    Ferris, Daron G.
    Paavonen, Jorma
    Steben, Marc
    Bosch, F. Xavier
    Dillner, Joakim
    Huh, Warner K.
    Joura, Elmar A.
    Kurman, Robert J.
    Majewski, Slawomir
    Myers, Evan R.
    Villa, Luisa L.
    Taddeo, Frank J.
    Roberts, Christine
    Tadesse, Amha
    Bryan, Janine T.
    Lupinacci, Lisa C.
    Giacoletti, Katherine E. D.
    Sings, Heather L.
    James, Margaret K.
    Hesley, Teresa M.
    Barr, Eliav
    Haupt, Richard M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05): : 325 - 339